Bresch Tells House Panel Mylan Nets $100 Per EpiPen Two-Unit Pack

September 21, 2016 at 9:00 PM
Mylan CEO Heather Bresch, facing bipartisan criticism over the pricing of EpiPen, told the House Oversight and Government Reform Committee Wednesday (Sept. 21) the company only nets a profit of approximately $100 per two-unit pack of EpiPen. The embattled CEO also laid out Mylan's plans to submit a new reformulation of EpiPen to FDA within days of the hearing, saying the company hoped to extend the shelf life of the drug from 18 months to 24 months or longer. The...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.